This is most likely due to heterogeneity of breast tumors, tumor sample sets, and the fact that the strongest correlation is in ER-positive 16 or in luminal B tumors 17, as observed in this study, as well as lower or nonexistent correlation in other subtypes such as the ERBB2 and basal subtypes. This evidence concerns the gene ERBB2 and neoplasm.